Cegedim SA (EPA:ALCGM)
France · Delayed Price · Currency is EUR 10.32
0.00 (0.00%)
Sep 11, 2026, 5:35 PM CET
Cegedim Market Cap
Cegedim has a market cap or net worth of €141.7 million as of September 11, 2026. Its market cap has increased by 1.80% in one year.
Market Cap
141.70M
Enterprise Value
391.00M
Revenue
649.17M
Ranking
n/a
PE Ratio
15.10
Stock Price
€10.32
ChartMarket Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 113.85M to 141.70M, an increase of 24.46%. That is a compound annual growth rate of 0.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 141.70M | -24.05% |
| Dec 31, 2025 | 186.56M | 6.71% |
| Dec 31, 2024 | 174.83M | -28.22% |
| Dec 29, 2023 | 243.57M | 22.47% |
| Dec 30, 2022 | 198.89M | -39.93% |
| Dec 31, 2021 | 331.11M | -6.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 87.77B |
| EssilorLuxottica Société anonyme | 67.28B |
| Sartorius Stedim Biotech | 18.18B |
| Ipsen | 12.88B |
| Eurobio Scientific Société anonyme | 204.39M |
| Cellectis | 191.49M |
| Bastide Le Confort Médical | 167.51M |
| Innate Pharma | 149.15M |